Cargando…
Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874015/ https://www.ncbi.nlm.nih.gov/pubmed/31798454 http://dx.doi.org/10.3389/fphar.2019.01358 |
| _version_ | 1783472763418181632 |
|---|---|
| author | Dai, Shuang Yan, Yuanliang Xu, Zhijie Zeng, Shuangshuang Qian, Long Huo, Lei Li, Xuejun Sun, Lunquan Gong, Zhicheng |
| author_facet | Dai, Shuang Yan, Yuanliang Xu, Zhijie Zeng, Shuangshuang Qian, Long Huo, Lei Li, Xuejun Sun, Lunquan Gong, Zhicheng |
| author_sort | Dai, Shuang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6874015 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68740152019-12-03 Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis Dai, Shuang Yan, Yuanliang Xu, Zhijie Zeng, Shuangshuang Qian, Long Huo, Lei Li, Xuejun Sun, Lunquan Gong, Zhicheng Front Pharmacol Pharmacology Frontiers Media S.A. 2019-11-15 /pmc/articles/PMC6874015/ /pubmed/31798454 http://dx.doi.org/10.3389/fphar.2019.01358 Text en Copyright © 2019 Dai, Yan, Xu, Zeng, Qian, Huo, Li, Sun and Gong http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Dai, Shuang Yan, Yuanliang Xu, Zhijie Zeng, Shuangshuang Qian, Long Huo, Lei Li, Xuejun Sun, Lunquan Gong, Zhicheng Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis |
| title | Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis |
| title_full | Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis |
| title_fullStr | Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis |
| title_full_unstemmed | Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis |
| title_short | Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis |
| title_sort | corrigendum: scd1 confers temozolomide resistance to human glioma cells via the akt/gsk3β/β-catenin signaling axis |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874015/ https://www.ncbi.nlm.nih.gov/pubmed/31798454 http://dx.doi.org/10.3389/fphar.2019.01358 |
| work_keys_str_mv | AT daishuang corrigendumscd1conferstemozolomideresistancetohumangliomacellsviatheaktgsk3bbcateninsignalingaxis AT yanyuanliang corrigendumscd1conferstemozolomideresistancetohumangliomacellsviatheaktgsk3bbcateninsignalingaxis AT xuzhijie corrigendumscd1conferstemozolomideresistancetohumangliomacellsviatheaktgsk3bbcateninsignalingaxis AT zengshuangshuang corrigendumscd1conferstemozolomideresistancetohumangliomacellsviatheaktgsk3bbcateninsignalingaxis AT qianlong corrigendumscd1conferstemozolomideresistancetohumangliomacellsviatheaktgsk3bbcateninsignalingaxis AT huolei corrigendumscd1conferstemozolomideresistancetohumangliomacellsviatheaktgsk3bbcateninsignalingaxis AT lixuejun corrigendumscd1conferstemozolomideresistancetohumangliomacellsviatheaktgsk3bbcateninsignalingaxis AT sunlunquan corrigendumscd1conferstemozolomideresistancetohumangliomacellsviatheaktgsk3bbcateninsignalingaxis AT gongzhicheng corrigendumscd1conferstemozolomideresistancetohumangliomacellsviatheaktgsk3bbcateninsignalingaxis |